Interface Selection for Adaptive Servo Ventilation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02919930 |
Recruitment Status : Unknown
Verified June 2016 by Universitaire Ziekenhuizen Leuven.
Recruitment status was: Recruiting
First Posted : September 30, 2016
Last Update Posted : September 30, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Central Sleep Apnea ASV | Device: Switch from oronasal to nasal mask during ASV treatment Device: Switch from nasal to oronasal mask during ASV treatment | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 15 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Interface Selection for Adaptive Servo Ventilation: A Randomized Controlled Study |
Study Start Date : | February 2015 |
Estimated Primary Completion Date : | February 2018 |
Estimated Study Completion Date : | February 2018 |
Arm | Intervention/treatment |
---|---|
Oronasal - Nasal
Patients undergo polysomnography with oronasal mask during the first night and nasal mask during the second night.
|
Device: Switch from oronasal to nasal mask during ASV treatment
One night of ASV treatment with oronasal mask followed by one night of ASV treatment with nasal mask. |
Nasal - Oronasal
Patients undergo polysomnography with nasal mask during the first night and oronasal mask during the second night.
|
Device: Switch from nasal to oronasal mask during ASV treatment
One night of ASV treatment with nasal mask followed by one night of ASV treatment with oronasal mask. |
- Apnea/hypopnea index [ Time Frame: Two nights ]Effect on respiratory events
- Mask comfort VAS [ Time Frame: Two nights ]Subjective mask comfort
- Device leaks data [ Time Frame: Two nights ]Evaluation of leaks (data of ASV device)
- Sleep efficiency [ Time Frame: Two nights ]polysomnographic evaluation
- Sleep architecture [ Time Frame: Two nights ]Polysomnographic evaluation of different sleep stages

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with central sleep apnea, not responding to treatment with CPAP
- Indication for treatment with ASV
Exclusion Criteria:
- Patients < 18 years old

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02919930
Contact: Dries Testelmans, MD, PhD | 00 32 16 342522 | dries.testelmans@uzleuven.be |
Belgium | |
UZ Leuven | Recruiting |
Leuven, Belgium, 3000 | |
Contact: Dries Testelmans, MD, PhD 00 32 16 342522 dries.testelmans@uzleuven.be | |
Sub-Investigator: Bart Vrijsen, MSc, PT |
Responsible Party: | Universitaire Ziekenhuizen Leuven |
ClinicalTrials.gov Identifier: | NCT02919930 |
Other Study ID Numbers: |
S57607 |
First Posted: | September 30, 2016 Key Record Dates |
Last Update Posted: | September 30, 2016 |
Last Verified: | June 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Sleep Apnea, Central Sleep Apnea Syndromes Apnea Respiration Disorders Respiratory Tract Diseases |
Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |